ARGENTINA

On March 25, provision 2198/2022 of the National Administration of Medicines (ANMAT) was published in the Official Gazette, which updates a series of administrative procedures regarding the registration of medical technology producers and products. 

The updated procedures include the registration in the Registry of Medical Technology Producers and Products (RPPTM in Spanish) of Group A, B, C and D in vitro diagnostic medical products, both domestic and imported. It also renews the procedures for the modification, transfer, revalidation and cancellation of the registers of Producers and Medical Products for in vitro diagnostics.

The measure seeks to advance in the state management process aimed at complying with the principles of efficiency, transparency and predictability and to adapt it to the standards of the new technological tools.